
Keywords: Diabetic kidney disease; diabetic nephropathy; renin-angiotensin system (RAS); RAS blockade; diabetes; end-stage kidney disease (ESKD); hemoglobin A1c (HbA1c); blood pressure; hypertension; angiotensin-converting enzyme inhibitor (ACEi); angiotensin recep